Luke Beshar

(Mr. Luke Beshar CPA)

Currently holds positions in Protara Therapeutics Inc, Trillium Therapeutics Inc and Regenxbio Inc

Positions

Position Company Period
Chairman of the Board Protara Therapeutics Inc Jan. 9, 2020 -
Independent Director Trillium Therapeutics Inc March 10, 2014 -
Independent Director Regenxbio Inc April 1, 2015 -
Chairman of the Board Entera Bio Ltd Dec. 1, 2016 - Aug. 9, 2018
Director Entera Bio Ltd Dec. 1, 2015 - Dec. 1, 2016
Chief Financial Officer, Executive Vice President Shire-Nps Pharmaceuticals Inc Jan. 1, 2011 - Feb. 20, 2015
Luke Beshar's trades of Protara Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-07-05 2022-06-30
B Purchase
10,000 +5.3%
3.10
USD 31,000 		10,000 +5.3% 3.10 USD 31,000
2022-03-16 2022-03-14
B Purchase
10,000 +5.6%
4.25
USD 42,500 		10,000 +5.6% 4.25 USD 42,500
2022-03-14 2022-03-10
B Purchase
10,000 +6.0%
4.46
USD 44,555 		10,000 +6.0% 4.46 USD 44,555
// ... existing code ... // ... rest of the file ...